Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1970 Oct;172(4):740–749. doi: 10.1097/00000658-197010000-00018

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

D L Morton, F R Eilber, W L Joseph, W C Wood, E Trahan, A S Ketcham
PMCID: PMC1397284  PMID: 5272336

Full text

PDF
742

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dore J. F., Motta R., Marholev L., Hrsak I., Colas de la Noue H., Seman G., De Vassal F., Mathé G. New antigens in human leukaemic cells and antibody in the serum of leukaemic patients. Lancet. 1967 Dec 30;2(7531):1396–1398. doi: 10.1016/s0140-6736(67)93027-9. [DOI] [PubMed] [Google Scholar]
  2. Eilber F. R., Morton D. L. Cutaneous anergy and prognosis following cancer surgery. Surg Forum. 1969;20:116–117. [PubMed] [Google Scholar]
  3. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Eilber F. R., Morton D. L. Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients. J Natl Cancer Inst. 1970 Mar;44(3):651–656. [PubMed] [Google Scholar]
  5. Everson T. C. Spontaneous regression of cancer. Ann N Y Acad Sci. 1964 Apr 2;114(2):721–735. [PubMed] [Google Scholar]
  6. FOLEY E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953 Dec;13(12):835–837. [PubMed] [Google Scholar]
  7. Fass L., Herberman R. B., Ziegler J. L., Kiryabwire J. W. Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet. 1970 Jan 17;1(7638):116–118. doi: 10.1016/s0140-6736(70)90467-8. [DOI] [PubMed] [Google Scholar]
  8. Fink M. A., Karon M., Rauscher F. J., Malmgren R. A., Orr H. C. Further observations on the immunofluorescence of cells in human leukemia. Cancer. 1965 Oct;18(10):1317–1321. doi: 10.1002/1097-0142(196510)18:10<1317::aid-cncr2820181018>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Hellström I. E., Hellström K. E., Pierce G. E., Bill A. H. Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1231–1238. doi: 10.1073/pnas.60.4.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hellström I., Hellström K. E., Pierce G. E., Yang J. P. Cellular and humoral immunity to different types of human neoplasms. Nature. 1968 Dec 28;220(5174):1352–1354. doi: 10.1038/2201352a0. [DOI] [PubMed] [Google Scholar]
  11. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kourilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst. 1967 Nov;39(5):1027–1044. [PubMed] [Google Scholar]
  13. Klein G. Tumor antigens. Annu Rev Microbiol. 1966;20:223–252. doi: 10.1146/annurev.mi.20.100166.001255. [DOI] [PubMed] [Google Scholar]
  14. Kronman B. S., Wepsic H. T., Churchill W. H., Jr, Zbar B., Borsos T., Rapp H. J. Immunotherapy of cancer: an experimental model in syngeneic guinea pigs. Science. 1970 Apr 10;168(3928):257–259. doi: 10.1126/science.168.3928.257. [DOI] [PubMed] [Google Scholar]
  15. Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Fairley G. H., Bodenham D. C., Alexander P. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J. 1969 Sep 6;3(5670):547–552. doi: 10.1136/bmj.3.5670.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lewis M. G. Possible immunological factors in human malignant melanoma in Uganda. Lancet. 1967 Oct 28;2(7522):921–922. doi: 10.1016/s0140-6736(67)90236-x. [DOI] [PubMed] [Google Scholar]
  17. Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697–699. doi: 10.1016/s0140-6736(69)92648-8. [DOI] [PubMed] [Google Scholar]
  18. Morton D. L. Cancer immunology and the surgeon. Surgery. 1970 Feb;67(2):396–398. [PubMed] [Google Scholar]
  19. Morton D. L., Malmgren R. A., Hall W. T., Schidlovsky G. Immunologic and virus studies with human sarcomas. Surgery. 1969 Jul;66(1):152–161. [PubMed] [Google Scholar]
  20. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  21. Muna N. M., Marcus S., Smart C. Detection by immunofluorescence of antibodies specific for human malignant melanoma cells. Cancer. 1969 Jan;23(1):88–93. doi: 10.1002/1097-0142(196901)23:1<88::aid-cncr2820230109>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  22. Nadler S. H., Moore G. E. Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes. Ann Surg. 1966 Sep;164(3):482–490. doi: 10.1097/00000658-196609000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. OLD L. J., BENACERRAF B., CLARKE D. A., CARSWELL E. A., STOCKERT E. The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 1961 Oct;21:1281–1300. [PubMed] [Google Scholar]
  24. Oettgen H. F., Aoki T., Old L. J., Boyse E. A., de Harven E., Mills G. M. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst. 1968 Oct;41(4):827–843. [PubMed] [Google Scholar]
  25. Old L. J., Boyse E. A. Antigens of tumors and leukemias induced by viruses. Fed Proc. 1965 Sep-Oct;24(5):1009–1017. [PubMed] [Google Scholar]
  26. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  28. Romsdahl M. M., Cox I. S. Immunofluorescent studies of antibodies against human malignant melanoma. Surg Forum. 1969;20:126–128. [PubMed] [Google Scholar]
  29. SUMNER W. C., FORAKER A. G. Spontaneous regression of human melanoma: clinical and experimental studies. Cancer. 1960 Jan-Feb;13:79–81. doi: 10.1002/1097-0142(196001/02)13:1<79::aid-cncr2820130115>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  30. Southam C. M. Evidence for cancer-specific angigens in man. Prog Exp Tumor Res. 1967;9:1–39. doi: 10.1159/000386011. [DOI] [PubMed] [Google Scholar]
  31. TEIMOURIAN B., MCCUNE W. S. SURGICAL MANAGEMENT OF MALIGNANT MELANOMA. Am Surg. 1963 Jul;29:515–519. [PubMed] [Google Scholar]
  32. WEISS D. W., BONHAG R. S., DEOME K. B. Protective activity of fractions of tubercle bacilli against isologous tumours in mice. Nature. 1961 Jun 3;190:889–891. doi: 10.1038/190889a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES